Stock THRX THESEUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Theseus Pharmaceuticals, Inc.

Equities

THRX

US88369M1018

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Theseus Pharmaceuticals, Inc. Announces Board Resignations
CI
Theseus Pharmaceuticals Announces Closing of Tender Offer
PR
Theseus Pharmaceuticals, Inc.(NasdaqGS:THRX) dropped from NASDAQ Composite Index
CI
Concentra Biosciences, LLC completed the acquisition of Theseus Pharmaceuticals, Inc..
CI
Theseus Pharmaceuticals, Inc.(NasdaqGS:THRX) dropped from S&P TMI Index
CI
Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals
BU
SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates DSKE, THRX, CONN
PR
THESEUS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Theseus Pharmaceuticals, Inc. - THRX
BU
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX, CONN
PR
Sector Update: Health Care Stocks Gain in Late Afternoon
MT
THRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholders
BU
Sector Update: Health Care Stocks Higher Friday Afternoon
MT
Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right
PR
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX
PR
Shareholder Alert: Ademi LLP investigates whether Theseus Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Concentra
PR
Sector Update: Health Care Stocks Mixed Premarket Friday
MT
Theseus Pharmaceuticals to be Acquired by Concentra Biosciences; Shares Rise Pre-Bell
MT
Theseus Pharmaceuticals, Inc. Announces Employment Termination of Timothy P. Clackson as Chief Executive Officer, Effective December 7, 2023
CI
Theseus Pharmaceuticals, Inc. Announces Management Changes
CI
Theseus Pharmaceuticals Receives Acquisition Offers From Foresite, OrbiMed, Concentra Biosciences
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. THRX Stock
  4. News Theseus Pharmaceuticals, Inc.